C. Fanelli

发表

Mechanisms of Insulin Resistance After Insulin-Induced Hypoglycemia in Humans: The Role of Lipolysis

P. Lucidi, P. Rossetti, F. Porcellati, 2010, Diabetes.

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

P. Brunetti, F. Porcellati, S. Pampanelli, 2000, Diabetes.

Long-Term Intensive Therapy of IDDM Patients With Clinically Overt Autonomic Neuropathy: Effects on Hypoglycemia Awareness and Counterregulation

P. Brunetti, F. Porcellati, S. Pampanelli, 1997, Diabetes.

Plasma Leptin and Insulin Relationships in Obese and Nonobese Humans

C. Fanelli, S. Dagogo-Jack, D. Paramore, 1996, Diabetes.

Durable reversal of hypoglycemia unawareness in type 1 diabetes.

P. Cryer, C. Fanelli, S. Dagogo-Jack, 1999, Diabetes care.

Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement

P. Lucidi, G. Perriello, C. Fanelli, 2003, Journal of endocrinological investigation.

Pharmacokinetics and Pharmacodynamics of Insulin Glargine Given in the Evening as Compared With in the Morning in Type 2 Diabetes

P. Lucidi, F. Porcellati, P. Candeloro, 2014, Diabetes Care.

Equipotency of insulin glargine 300 and 100 U/mL with intravenous dosing but differential bioavailability with subcutaneous dosing in dogs

N. Tennagels, G. Bolli, C. Fanelli, 2020, Diabetes, obesity & metabolism.

Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population.

D. Cucinotta, A. Avogaro, G. Bolli, 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

How to Accurately Establish Pharmacokinetics/Pharmacodynamics of Long-Acting Insulins in Humans: Relevance to Biosimilar Insulins

P. Lucidi, F. Porcellati, G. Bolli, 2015, Diabetes Care.

Forearm norepinephrine spillover during standing, hyperinsulinemia, and hypoglycemia.

P. Cryer, C. Fanelli, D. Paramore, 1998, American journal of physiology. Endocrinology and metabolism.

Is physical activity a necessary element during Italian coronavirus disease emergency? Yes or no debate

C. Fanelli, R. Pippi, 2021 .

Pharmacokinetics and pharmacodynamics of basal insulins.

F. Porcellati, G. Bolli, C. Fanelli, 2011, Diabetes technology & therapeutics.

Evaluation of maximum oxygen consumption in obese adolescents before and after a multidisciplinary lifestyle intervention

C. Fanelli, R. Pippi, F. Perna, 2020 .

Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes.

T. Videen, C. Dence, J. Markham, 1998, Diabetes.

Physical activity level and mediterranean diet adherence evaluation in older people - observational, uncontrolled, pilot study

C. Fanelli, R. Pippi, L. Pasqualini, 2022, Physical Activity Review.

Effect of Short Term Intensive Lifestyle Intervention on Hepatic Steatosis Indexes in Adults with Obesity and/or Type 2 Diabetes

G. Marchesini, V. Bini, C. Fanelli, 2019, Journal of clinical medicine.

Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection

P. Lucidi, F. Porcellati, P. Candeloro, 2015, Diabetes Care.

An intensive lifestyle intervention in children with attention-deficit/hyperactivity disorder

C. Fanelli, Clarissa Cavallina, P. Feo, 2019, Gazzetta Medica Italiana Archivio per le Scienze Mediche.

Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes

P. Lucidi, P. Rossetti, F. Porcellati, 2012, Diabetes Care.

Efficacy of the holistic, psychonutritional approach of Centro DAI e Obesità di Città della Pieve in the management of type 2 diabetes among patients with obesity and dysfunctional eating

S. Pampanelli, C. Fanelli, G. Colleluori, 2022, Journal of Diabetes & Metabolic Disorders.

Mechanisms of Arterial Hypotension After Therapeutic Dose of Subcutaneous Insulin in Diabetic Autonomic Neuropathy

P. Brunetti, F. Porcellati, S. Pampanelli, 1993, Diabetes.

Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects

P. Lucidi, P. Rossetti, F. Porcellati, 2011, Diabetes Care.

of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects A randomized cross-over study

P. Lucidi, A. Andreoli, G. Bolli, 2011 .

Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH , Glargine , and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetes

P. Rossetti, F. Porcellati, P. Candeloro, 2011 .

Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia.

P. Lucidi, G. Bolli, C. Fanelli, 2002, Diabetes.

Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128–2136

P. Lucidi, F. Porcellati, G. Bolli, 2021, Diabetes Care.

GREATER SUPPRESSION OF GLUCAGON, LIPOLYSIS AND KETOGENESIS WITH INSULIN GLARGINE U300 AS COMPARED TO GLARGINE U100 IN TYPE 1 DIABETES MELLITUS.

P. Lucidi, F. Porcellati, P. Candeloro, 2020, Diabetes technology & therapeutics.

Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus

P. Lucidi, P. Rossetti, F. Porcellati, 2011, Diabetes Care.

Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus

F. Porcellati, A. Andreoli, G. Bolli, 2011 .

Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations.

E. Ghigo, P. Lucidi, G. Bolli, 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

“Strength gains in different age groups of overweight/obese adults: A pilot uncontrolled study”

C. Fanelli, P. De Feo, E. Reginato, 2022, Cogent Social Sciences.

Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People

K. Nair, P. Rossetti, F. Porcellati, 2008, Diabetes.

Effects of a Mixed Exercise Program on Overweight and Obese Children and Adolescents: A Pilot, Uncontrolled Study

G. Mascherini, V. Bini, C. Fanelli, 2022, International journal of environmental research and public health.

Efficacy of the holistic, psychonutritional approach of Centro DAI e Obesità di Città della Pieve in the management of type 2 diabetes among patients with obesity and dysfunctional eating

S. Pampanelli, C. Fanelli, G. Colleluori, 2022, Journal of Diabetes & Metabolic Disorders.

Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes

D. Owens, P. Lucidi, P. Rossetti, 2007, Diabetes Care.

Insulin is required for prandial ghrelin suppression in humans.

P. Lucidi, G. Bolli, C. Fanelli, 2003, Diabetes.

Meticulous Prevention of Hypoglycemia Normalizes the Glycemic Thresholds and Magnitude of Most of Neuroendocrine Responses to, Symptoms of, and Cognitive Function During Hypoglycemia in Intensively Treated Patients With Short-Term IDDM

Paolo Brunetti, P. Brunetti, F. Porcellati, 1993, Diabetes.

Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes

P. Rossetti, F. Porcellati, G. Bolli, 2008, Diabetes Care.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes.

Chiara Taglioni, P. Lucidi, C. Fanelli, 2005, Diabetes care.

Effects of an Intensive Lifestyle Intervention to Treat Overweight/Obese Children and Adolescents

C. Fanelli, P. De Feo, V. Gianfredi, 2017, BioMed research international.

Insulin therapy and hypoglycaemia: the size of the problem

F. Porcellati, S. Pampanelli, G. Bolli, 2004, Diabetes/metabolism research and reviews.

Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia.

T. Videen, C. Dence, J. Markham, 2001, Diabetes.

Impact of patient and treatment characteristics on glycemic control and hypoglycemia in patients with type 2 diabetes initiated to insulin glargine or NPH

P. Lucidi, F. Porcellati, G. Bolli, 2017, Medicine.

Pivotal Role of Timely Basal Insulin Replacement After Metformin Failure in Sustaining Long-Term Blood Glucose Control at a Target in Type 2 Diabetes

P. Lucidi, F. Porcellati, G. Bolli, 2011, Diabetes Care.

Effects of a Supervised Nordic Walking Program on Obese Adults with and without Type 2 Diabetes: The C.U.R.I.A.Mo. Centre Experience

L. Cugusi, A. di Blasio, S. Gobbo, 2020, Journal of functional morphology and kinesiology.

Validation of a counseling strategy to promote the adoption and the maintenance of physical activity by type 2 diabetic subjects.

P. Brunetti, P. Lucidi, C. Fanelli, 2003, Diabetes care.

Forearm norepinephrine spillover during standing, hyperinsulinemia, and hypoglycemia.

P. Cryer, C. Fanelli, D. Paramore, 1998, The American journal of physiology.

Portal Vein Glucose Sensors Do Not Play a Major Role in Modulating Physiological Responses to Insulin-Induced Hypoglycemia in Humans

P. Lucidi, P. Rossetti, F. Porcellati, 2009, Diabetes.

Type 1 Diabetes (T1D) and Latent Autoimmune Diabetes in Adults (LADA): The Difference Between a Honeymoon and a Holiday

C. Fanelli, R. Calafiore, L. Marcon, 2022, Case reports in endocrinology.

Intensive lifestyle intervention is particularly advantageous in poorly controlled type 2 diabetes.

C. Fanelli, P. De Feo, E. Reginato, 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Different Brain Responses to Hypoglycemia Induced by Equipotent Doses of the Long-Acting Insulin Analog Detemir and Human Regular Insulin in Humans

P. Rossetti, F. Porcellati, P. Candeloro, 2008, Diabetes.

Thirty Years of Research on the Dawn Phenomenon: Lessons to Optimize Blood Glucose Control in Diabetes

P. Lucidi, F. Porcellati, G. Bolli, 2013, Diabetes Care.

Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus

Paolo Rossetti, Carmine G. Fanelli, P. Rossetti, 2008 .

Supervised Exercise in Water: Is It a Viable Alternative in Overweight/Obese People with or without Type 2 Diabetes? A Pilot Study

V. Bini, C. Fanelli, M. Vandoni, 2022, Nutrients.

Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin?

S. Piro, F. Purrello, R. Malaguarnera, 2021, Biomolecules.

Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology

P. Lucidi, F. Porcellati, G. Bolli, 2018, Current Diabetes Reports.

Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.

Paolo Rossetti, P. Rossetti, F. Porcellati, 2003, Diabetes care.

Impact of BMI, Physical Activity, and Sitting Time Levels on Health-Related Outcomes in a Group of Overweight and Obese Adults with and without Type 2 Diabetes

L. Cugusi, V. Bini, A. di Blasio, 2022, Journal of functional morphology and kinesiology.

Are three months multidisciplinary lifestyle intervention enough to get benefits on blood pressure in overweight/obese adults ?

V. Bini, C. Fanelli, E. Reginato, 2021 .

Physical Activity Habits and Well-Being among 6-Year-Old Children: The “Improving Umbrian Kids’ Healthy Lifestyle”, an Uncontrolled Pilot Study Project

C. Fanelli, R. Pippi, C. Mazzeschi, 2020, International journal of environmental research and public health.

Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes.

P. Cryer, T. Hershey, S. Craft, 1998, Diabetes.

Impact of Recent Antecedent Hypoglycemia on Hypoglycemic Cognitive Dysfunction in Nondiabetic Humans

P. Cryer, T. Hershey, S. Craft, 1996, Diabetes.

Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus.

P. Rossetti, F. Porcellati, G. Perriello, 2008, Archives of physiology and biochemistry.

Effects of Recent, Short-Term Hyperglycemia on Responses to Hypoglycemia in Humans: Relevance to the Pathogenesis of Hypoglycemia Unawareness and Hyperglycemia-Induced Insulin Resistance

P. Brunetti, S. Pampanelli, G. Bolli, 1995, Diabetes.

One-hundred year evolution of prandial insulin preparations: from animal pancreas extracts to rapid-ACTING analogs.

D. Owens, P. Lucidi, F. Porcellati, 2021, Metabolism: clinical and experimental.

Counterregulatory responses in CSII

P. Rossetti, C. Fanelli, 2006 .

Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: a Double-Blind, Randomized, Crossover Study

P. Rossetti, F. Porcellati, G. Bolli, 2008, Diabetes Care.

Estimating Plasma Glucose from Interstitial Glucose: The Issue of Calibration Algorithms in Commercial Continuous Glucose Monitoring Devices

Josep Vehí, Jorge Bondia, Paolo Rossetti, 2010, Sensors.

Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes

P. Lucidi, F. Porcellati, P. Candeloro, 2018, Diabetes Care.

Review for "Pharmacokinetic and pharmacodynamic bioequivalence between regular human insulin ( rDNA origin) in 0.9% sodium chloride ready‐to‐use infusion 1 U / mL and 100 U / mL concentrate diluted to 1 U / mL in healthy males"

C. Fanelli, 2021 .

Early Improvement of Glucose Tolerance after Ileal Transposition in a Non-obese Type 2 Diabetes Rat Model

C. Fanelli, A. Patriti, A. Donini, 2005, Obesity surgery.

Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans

P. Brunetti, S. Pampanelli, G. Bolli, 1994, Diabetologia.

Nocturnal Blood Glucose Control in Type I Diabetes Mellitus

G. Perriello, G. Bolli, C. Fanelli, 1993, Diabetes Care.

THE ROLE OF GASTRIC EMPTYING IN GLUCOSE HOMEOSTASIS AND DEFENSE AGAINST HYPOGLYCEMIA: INNOCENT BYSTANDER OR PARTNER IN CRIME?

P. Lucidi, F. Porcellati, G. Bolli, 2023, Diabetes research and clinical practice.

Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans.

E. Ghigo, P. Lucidi, P. Rossetti, 2009, The Journal of clinical endocrinology and metabolism.

Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans.

P. Rossetti, F. Porcellati, S. Pampanelli, 2003, Diabetes.

The dawn phenomenon in Type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity

P. De Feo, G. Perriello, G. Bolli, 2004, Diabetologia.

Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus.

P. Cryer, T. Hershey, S. Craft, 1998, Diabetes.

Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM

P. De Feo, P. Brunetti, S. Pampanelli, 1994, Diabetologia.

Adherence to nutritional follow-up after laparoscopic sleeve gastrectomy: a single center experience in the Umbria region in Italy

C. Fanelli, G. Lupattelli, R. Pippi, 2022, Chirurgia.

A multistep approach for the stratification of the risk of severe hypoglycemia in patients with type 2 diabetes.

R. Napoli, F. Giorgino, A. Nicolucci, 2018, Minerva Endocrinologica.

Comparable efficacy with similarly low risk of hypoglycaemia in patient‐ vs physician‐managed basal insulin initiation and titration in insulin‐naïve type 2 diabetic subjects: The Italian Titration Approach Study

D. Cucinotta, A. Avogaro, G. Bolli, 2020, Diabetes/metabolism research and reviews.

A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules

P. Lucidi, C. Fanelli, C. Fanelli, 2006, Journal of endocrinological investigation.

Contribution of cortisol to glucose counterregulation in humans.

F Santeusanio, C Fanelli, P. Brunetti, 1989, The American journal of physiology.

Reversibility of unawareness of hypoglycemia in patients with insulinomas.

P. Cryer, P. Brunetti, G. Perriello, 1993, The New England journal of medicine.

GLP-1 RAs as compared to prandial insulin after failure of basal insulin in type 2 diabetes: lessons from the 4B and Get-Goal DUO 2 trials.

P. Lucidi, F. Porcellati, G. Bolli, 2015, Diabetes & metabolism.

Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in Type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning

P. Brunetti, G. Perriello, G. Bolli, 2004, Diabetologia.

Physiology of glucose counterregulation to hypoglycemia.

G. Bolli, C. Fanelli, C. Fanelli, 1999, Endocrinology and metabolism clinics of North America.

The physiological basis of insulin therapy in people with diabetes mellitus.

P. Lucidi, F. Porcellati, G. Bolli, 2021, Diabetes research and clinical practice.

P. Lucidi, C. Fanelli, C. Fanelli, 2004, Journal of endocrinological investigation.

Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis.

P. Brunetti, F. Porcellati, G. Perriello, 1992, The Journal of clinical investigation.

Better long‐term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal‐time lispro insulin

P. Rossetti, F. Porcellati, S. Pampanelli, 2004, Diabetic medicine : a journal of the British Diabetic Association.

Administration of Neutral Protamine Hagedorn Insulin at Bedtime versus with Dinner in Type 1 Diabetes Mellitus To Avoid Nocturnal Hypoglycemia and Improve Control

P. Brunetti, P. Rossetti, F. Porcellati, 2002, Annals of Internal Medicine.

Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia

S. Pampanelli, G. Bolli, C. Fanelli, 1996, Diabetologia.

Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM

P. Brunetti, S. Pampanelli, G. Bolli, 1994, Diabetologia.

Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state

P. Rossetti, F. Porcellati, S. Pampanelli, 2002, Diabetologia.

Unraveling Barriers to a Healthy Lifestyle: Understanding Barriers to Diet and Physical Activity in Patients with Chronic Non-Communicable Diseases

G. Pucci, C. Fanelli, M. Vandoni, 2023, Nutrients.

Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus

M. Motolese, P. Brunetti, F. Porcellati, 2006, European Journal of Clinical Pharmacology.

Hypoglycemia

P. Lucidi, F. Porcellati, G. Bolli, 2019, The APRN and PA’s Complete Guide to Prescribing Drug Therapy.

Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: a dose-response study.

P. Lucidi, F. Porcellati, P. Candeloro, 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.